OBJECTIVE: To describe emergency department (ED) management of older children with sickle cell disease (SCD) experiencing a vaso-occlusive episode (VOE) and factors associated with disposition and ED return. STUDY DESIGN: We retrospectively reviewed ED visits of children age >/=8 years with SCD over the course of 1 year. Data were collected from the electronic medical record and the SCD database. RESULTS: VOE was diagnosed 279 times in 105 patients; 45 of the patients had 1 ED visit, 25 had 2 ED visits, and 16 had >/=5 ED visits. The overall admission rate was 178/279 (64%), 166 on the first ED visit and 12 on a return visit within 72 hours. Use of home opioids, duration of VOE, and hemoglobin concentration were not associated with disposition. Discharge after 2 doses of intravenous (IV) morphine occurred in 33 patients. Pain relief after 1 dose, using a FACES scale of 1 to 5, differed significantly between the admitted patients and the discharged patients (1.1 vs 2.5; P < .0001). CONCLUSION: Suboptimal pain relief after 1 dose of IV morphine was associated with admission from the ED. Further investigation of pain relief, using validated pain assessment scales, as an outcome in VOE management is warranted.
OBJECTIVE: To describe emergency department (ED) management of older children with sickle cell disease (SCD) experiencing a vaso-occlusive episode (VOE) and factors associated with disposition and ED return. STUDY DESIGN: We retrospectively reviewed ED visits of children age >/=8 years with SCD over the course of 1 year. Data were collected from the electronic medical record and the SCD database. RESULTS: VOE was diagnosed 279 times in 105 patients; 45 of the patients had 1 ED visit, 25 had 2 ED visits, and 16 had >/=5 ED visits. The overall admission rate was 178/279 (64%), 166 on the first ED visit and 12 on a return visit within 72 hours. Use of home opioids, duration of VOE, and hemoglobin concentration were not associated with disposition. Discharge after 2 doses of intravenous (IV) morphine occurred in 33 patients. Pain relief after 1 dose, using a FACES scale of 1 to 5, differed significantly between the admitted patients and the discharged patients (1.1 vs 2.5; P < .0001). CONCLUSION: Suboptimal pain relief after 1 dose of IV morphine was associated with admission from the ED. Further investigation of pain relief, using validated pain assessment scales, as an outcome in VOE management is warranted.
Authors: Carlton Dampier; B N Yamaja Setty; Barry Eggleston; Darcy Brodecki; Patricia O'neal; Marie Stuart Journal: J Pediatr Hematol Oncol Date: 2004-12 Impact factor: 1.289
Authors: Bret P Nelson; David Cohen; Owen Lander; Nicole Crawford; Asa W Viccellio; Adam J Singer Journal: Am J Emerg Med Date: 2004-11 Impact factor: 2.469
Authors: O S Platt; B D Thorington; D J Brambilla; P F Milner; W F Rosse; E Vichinsky; T R Kinney Journal: N Engl J Med Date: 1991-07-04 Impact factor: 91.245
Authors: O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug Journal: N Engl J Med Date: 1994-06-09 Impact factor: 91.245
Authors: Julie A Wolfson; Sheree M Schrager; Rachna Khanna; Thomas D Coates; Michele D Kipke Journal: Pediatr Blood Cancer Date: 2011-02-25 Impact factor: 3.167
Authors: Jean L Raphael; Tiffany L Rattler; Marc A Kowalkowski; David C Brousseau; Brigitta U Mueller; Thomas P Giordano Journal: J Natl Med Assoc Date: 2013 Impact factor: 1.798
Authors: Jennifer Horst; Melissa Frei-Jones; Elena Deych; William Shannon; Evan D Kharasch Journal: Pediatr Blood Cancer Date: 2016-08-30 Impact factor: 3.167
Authors: Carlton D Dampier; Wally R Smith; Carrie G Wager; Hae-Young Kim; Margaret C Bell; Scott T Miller; Debra L Weiner; Caterina P Minniti; Lakshmanan Krishnamurti; Kenneth I Ataga; James R Eckman; Lewis L Hsu; Donna McClish; Sonja M McKinlay; Robert Molokie; Ifeyinwa Osunkwo; Kim Smith-Whitley; Marilyn J Telen Journal: Clin Trials Date: 2013-04 Impact factor: 2.486
Authors: Claudia R Morris; Frans A Kuypers; Lisa Lavrisha; Michael Ansari; Nancy Sweeters; Melinee Stewart; Ginny Gildengorin; Lynne Neumayr; Elliott P Vichinsky Journal: Haematologica Date: 2013-05-03 Impact factor: 9.941
Authors: Michael Joseph Barrett; John Cronin; Adrian Murphy; Siobhan McCoy; John Hayden; SinéadNic an Fhailí; Tim Grant; Abel Wakai; Corrina McMahon; Sean Walsh; Ronan O'Sullivan Journal: Trials Date: 2012-05-30 Impact factor: 2.279